| Date | Form | Description | Docs | XBRL | Pages |
| 09/30/22 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 09/29/22 | 8-K | Current report filing |
|
|
14 |
| 09/19/22 | EFFECT | Notice of Effectiveness |
|
1 | |
| 09/16/22 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 09/16/22 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 09/15/22 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
1 | |
| 09/14/22 | UPLOAD | SEC-generated letter |
|
1 | |
| 09/12/22 | DEL AM | Separately filed delaying amendment under Securities Act Rule 473 to delay effectiveness of a 1933 Act registration statement |
|
1 | |
| 09/09/22 | S-3 | Registration statement for specified transactions by certain issuers |
|
68 | |
| 09/09/22 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
21 |
Latest News & Events
Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Ovarian Cancer Research Alliance's International Gynecologic Cancer Conference
Read More...Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium
Read More...Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Read More...